A clinical trial update was posted on September 9, 2026, for a study involving mazdutide. The trial, registered as NCT07809945 and titled "A Study of IBI3046 in Participants With Overweight or Obesity," is listed as Phase 1. According to the registry, the study status is currently "not yet recruiting."
The trial record does not include information on results, safety findings, or efficacy outcomes at this stage. Mazdutide remains classified as unapproved and in research status, and this update reflects only administrative trial registration information, not clinical findings.
As the study has not begun recruiting participants, no data on dosing, participant outcomes, or trial progress are available at this time. Further updates would be expected as the trial status changes, such as when recruitment begins or interim data become available.
Readers interested in background on this compound, including its research history and current regulatory status, can consult the mazdutide compound overview for additional context.